Ümmügülsüm Can

535 total citations
35 papers, 414 citations indexed

About

Ümmügülsüm Can is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ümmügülsüm Can has authored 35 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Endocrine and Autonomic Systems and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ümmügülsüm Can's work include Regulation of Appetite and Obesity (5 papers), Biomarkers in Disease Mechanisms (4 papers) and Vitamin D Research Studies (4 papers). Ümmügülsüm Can is often cited by papers focused on Regulation of Appetite and Obesity (5 papers), Biomarkers in Disease Mechanisms (4 papers) and Vitamin D Research Studies (4 papers). Ümmügülsüm Can collaborates with scholars based in Türkiye, United States and France. Ümmügülsüm Can's co-authors include Fatma Hümeyra Yerlikaya, Muammer Büyükinan, Şebnem Yosunkaya, Asuman Güzelant, Hüsniye Başer, Özgür Pirgon, Hüseyin Bekir Yıldız, Kadri Murat Gürses, Oktay Talaz and Emine Guler and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and RSC Advances.

In The Last Decade

Ümmügülsüm Can

30 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ümmügülsüm Can Türkiye 12 106 98 80 70 65 35 414
Yongli Zhao China 12 204 1.9× 62 0.6× 78 1.0× 52 0.7× 63 1.0× 32 474
Cherley Borba Vieira de Andrade Brazil 14 86 0.8× 68 0.7× 24 0.3× 53 0.8× 36 0.6× 49 457
Zhijian Yang China 13 174 1.6× 70 0.7× 118 1.5× 62 0.9× 17 0.3× 28 480
Agata Wrońska Poland 12 189 1.8× 296 3.0× 69 0.9× 160 2.3× 53 0.8× 24 657
Jingjing Da China 11 109 1.0× 53 0.5× 34 0.4× 39 0.6× 52 0.8× 48 431
Stephen Bennett United Kingdom 8 200 1.9× 169 1.7× 38 0.5× 29 0.4× 123 1.9× 22 505

Countries citing papers authored by Ümmügülsüm Can

Since Specialization
Citations

This map shows the geographic impact of Ümmügülsüm Can's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ümmügülsüm Can with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ümmügülsüm Can more than expected).

Fields of papers citing papers by Ümmügülsüm Can

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ümmügülsüm Can. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ümmügülsüm Can. The network helps show where Ümmügülsüm Can may publish in the future.

Co-authorship network of co-authors of Ümmügülsüm Can

This figure shows the co-authorship network connecting the top 25 collaborators of Ümmügülsüm Can. A scholar is included among the top collaborators of Ümmügülsüm Can based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ümmügülsüm Can. Ümmügülsüm Can is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Can, Ümmügülsüm, et al.. (2025). Spexin as a potential biomarker for autoimmune inflammation in Graves’ disease. Journal of Investigative Medicine. 73(8). 634–642. 1 indexed citations
3.
Can, Ümmügülsüm, et al.. (2024). Comparison of cord blood alarin levels of full-term infants according to birth weight. Journal of Perinatal Medicine. 53(1). 110–116.
4.
Can, Ümmügülsüm, et al.. (2024). Serum Endocan Levels in Children with Acute Rheumatic Fever. Nigerian Journal of Clinical Practice. 27(9). 1051–1056.
5.
Can, Ümmügülsüm, et al.. (2024). The Levels of Phoenixin-14 and Phoenixin-20 in Patients with Type 2Diabetes Mellitus. Endocrine Metabolic & Immune Disorders - Drug Targets. 24(11). 1315–1322. 1 indexed citations
6.
Can, Ümmügülsüm, et al.. (2023). Are decreased cocaine- and amphetamine regulated transcript and Agouti- related peptide levels associated Eating behavior in medication-free children with attention deficit and hyperactivity disorder?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 129. 110907–110907. 1 indexed citations
8.
Can, Ümmügülsüm, et al.. (2022). Some miRNA expressions and their targets in ischemic stroke. Nucleosides Nucleotides & Nucleic Acids. 41(11). 1224–1262. 6 indexed citations
9.
Can, Ümmügülsüm, et al.. (2021). Serum sclerostin level and its relation to subclinical atherosclerosis in the polycystic ovary syndrome phenotypes: A prospective controlled study. Journal of Turkish Society of Obstetric and Gynecology. 18(3). 167–174.
10.
Büyükinan, Muammer, et al.. (2018). The Association Between Serum Vaspin and Omentin-1 Levels in Obese Children with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 16(2). 76–81. 33 indexed citations
11.
Can, Ümmügülsüm, et al.. (2017). Enhanced serum levels of matrix Gla protein and bone morphogenetic protein in acute coronary syndrome patients. Journal of Clinical Laboratory Analysis. 32(3). 6 indexed citations
12.
Can, Ümmügülsüm, Muammer Büyükinan, & Fatma Hümeyra Yerlikaya. (2017). Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity. The Indian Journal of Medical Research. 145(3). 327–333. 6 indexed citations
13.
Can, Ümmügülsüm & Şebnem Yosunkaya. (2017). A New Marker for Ischemia: Ischemia-modified Albumin. SHILAP Revista de lepidopterología. 20(2). 148–152. 6 indexed citations
14.
Can, Ümmügülsüm. (2016). Effects Of HIgh-Fat DIet And AcrylamIde On TIssue OxIdant AndantIoxIdant Levels In Rats. 32(2). 38–42. 1 indexed citations
15.
Can, Ümmügülsüm, et al.. (2016). Investigation of the inflammatory biomarkers of metabolic syndrome in adolescents. Journal of Pediatric Endocrinology and Metabolism. 0(0). 1277–1283. 13 indexed citations
16.
Yosunkaya, Şebnem, et al.. (2015). Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome. Metabolic Syndrome and Related Disorders. 13(6). 272–277. 10 indexed citations
17.
Can, Ümmügülsüm, Fatma Hümeyra Yerlikaya, & Şebnem Yosunkaya. (2015). Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease. Journal of the Chinese Medical Association. 78(12). 702–708. 39 indexed citations
18.
Başer, Hüsniye, et al.. (2014). Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine. 48(3). 916–923. 61 indexed citations
19.
Can, Ümmügülsüm, Asuman Güzelant, Fatma Hümeyra Yerlikaya, & Şebnem Yosunkaya. (2014). The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease. Journal of Investigative Medicine. 62(7). 938–943. 13 indexed citations
20.
Gültekin, Fatih, et al.. (1997). Effect of moderate alcohol intake on lipid peroxidation in plasma, erythrocyte and leukocyte and on some antioxidant enzymes. Clinica Chimica Acta. 266(2). 141–147. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026